Latino Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) in Treatment-Naive Patients With Chronic Hepatitis C-Genotype 1.

NCT00107653 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

569

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: Ribavirin
DRUG: Peginterferon alfa-2a
DRUG: Ribavirin
DRUG: Peginterferon alfa-2a

Sponsor

Hoffmann-La Roche